Correlation Between Kancera AB and Acarix AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kancera AB and Acarix AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kancera AB and Acarix AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kancera AB and Acarix AS, you can compare the effects of market volatilities on Kancera AB and Acarix AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kancera AB with a short position of Acarix AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kancera AB and Acarix AS.

Diversification Opportunities for Kancera AB and Acarix AS

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Kancera and Acarix is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Kancera AB and Acarix AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acarix AS and Kancera AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kancera AB are associated (or correlated) with Acarix AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acarix AS has no effect on the direction of Kancera AB i.e., Kancera AB and Acarix AS go up and down completely randomly.

Pair Corralation between Kancera AB and Acarix AS

Assuming the 90 days trading horizon Kancera AB is expected to generate 3.26 times more return on investment than Acarix AS. However, Kancera AB is 3.26 times more volatile than Acarix AS. It trades about 0.15 of its potential returns per unit of risk. Acarix AS is currently generating about -0.22 per unit of risk. If you would invest  96.00  in Kancera AB on September 13, 2024 and sell it today you would earn a total of  26.00  from holding Kancera AB or generate 27.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Kancera AB  vs.  Acarix AS

 Performance 
       Timeline  
Kancera AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kancera AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Acarix AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acarix AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Acarix AS is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Kancera AB and Acarix AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kancera AB and Acarix AS

The main advantage of trading using opposite Kancera AB and Acarix AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kancera AB position performs unexpectedly, Acarix AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acarix AS will offset losses from the drop in Acarix AS's long position.
The idea behind Kancera AB and Acarix AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk